LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Alvocidib | 3.33 | uM | LJP6 | 1 | A14 | 72 | hr | 1389 | 433 | 5147 | 0.0841 | -0.4604 |
| MCF7 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 1389 | 1508 | 5447 | 0.2768 | 0.0426 |
| MCF7 | CP466722 | 3.33 | uM | LJP5 | 1 | I08 | 72 | hr | 1389 | 5909 | 5772 | 1.0236 | 1.0229 |
| MCF7 | CP724714 | 3.33 | uM | LJP5 | 3 | A08 | 72 | hr | 1389 | 5037 | 6038 | 0.8342 | 0.8360 |
| MCF7 | Alvocidib | 3.33 | uM | LJP6 | 3 | A14 | 72 | hr | 1389 | 485 | 5740 | 0.0845 | -0.4019 |
| MCF7 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 1389 | 1347 | 5147 | 0.2617 | -0.0161 |
| MCF7 | Sorafenib | 3.33 | uM | LJP6 | 1 | B08 | 72 | hr | 1389 | 3484 | 5147 | 0.6769 | 0.6268 |
| MCF7 | Sorafenib | 3.33 | uM | LJP6 | 3 | B08 | 72 | hr | 1389 | 5078 | 5740 | 0.8846 | 0.8837 |
| MCF7 | AZD7762 | 3.33 | uM | LJP6 | 2 | L02 | 72 | hr | 1389 | 1238 | 5447 | 0.2272 | -0.0567 |
| MCF7 | CP724714 | 3.33 | uM | LJP5 | 1 | A08 | 72 | hr | 1389 | 5082 | 5772 | 0.8804 | 0.8798 |
| MCF7 | Alvocidib | 3.33 | uM | LJP6 | 2 | A14 | 72 | hr | 1389 | 486 | 5447 | 0.0892 | -0.4130 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 1 | A08 | 72 | hr | 1389 | 1261 | 5147 | 0.2450 | -0.0499 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 3 | A08 | 72 | hr | 1389 | 1575 | 5740 | 0.2744 | 0.0633 |
| MCF7 | AT-7519 | 3.33 | uM | LJP6 | 3 | K02 | 72 | hr | 1389 | 472 | 5740 | 0.0822 | -0.4098 |
| MCF7 | AT-7519 | 3.33 | uM | LJP6 | 1 | K02 | 72 | hr | 1389 | 542 | 5147 | 0.1053 | -0.3923 |
| MCF7 | AT-7519 | 3.33 | uM | LJP6 | 2 | K02 | 72 | hr | 1389 | 424 | 5447 | 0.0778 | -0.4522 |
| MCF7 | Seliciclib | 3.33 | uM | LJP5 | 1 | J02 | 72 | hr | 1389 | 4584 | 5772 | 0.7941 | 0.7878 |
| MCF7 | Sorafenib | 3.33 | uM | LJP6 | 2 | B08 | 72 | hr | 1389 | 4612 | 5447 | 0.8466 | 0.8380 |
| MCF7 | Seliciclib | 3.33 | uM | LJP5 | 3 | J02 | 72 | hr | 1389 | 5104 | 6038 | 0.8452 | 0.8475 |
| MCF7 | AZD7762 | 3.33 | uM | LJP6 | 1 | L02 | 72 | hr | 1389 | 936 | 5147 | 0.1819 | -0.1885 |
| MCF7 | AZD7762 | 3.33 | uM | LJP6 | 3 | L02 | 72 | hr | 1389 | 1122 | 5740 | 0.1955 | -0.0990 |
| MCF7 | CP466722 | 3.33 | uM | LJP5 | 3 | I08 | 72 | hr | 1389 | 5924 | 6038 | 0.9810 | 0.9820 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 2 | A08 | 72 | hr | 1389 | 1403 | 5447 | 0.2575 | 0.0051 |
| MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 1389 | 1569 | 5772 | 0.2718 | 0.0611 |
| MCF7 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 1389 | 1611 | 5740 | 0.2806 | 0.0751 |